BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 18929062)

  • 1. Use of psychotropic medications in children with developmental disabilities.
    Calles JL
    Pediatr Clin North Am; 2008 Oct; 55(5):1227-40, ix. PubMed ID: 18929062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.
    Matson JL; Neal D
    Res Dev Disabil; 2009; 30(3):572-86. PubMed ID: 18845418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designs and analyses of psychotropic and behavioral interventions for the treatment of problem behavior among people with intellectual and developmental disabilities.
    Courtemanche AB; Schroeder SR; Sheldon JB
    Am J Intellect Dev Disabil; 2011 Jul; 116(4):315-28. PubMed ID: 21740259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal alcohol syndrome in developmental age. Neuropsychiatric aspects.
    Roccella M; Testa D
    Minerva Pediatr; 2003 Feb; 55(1):63-9, 69-74. PubMed ID: 12660628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic medication use in people with developmental disabilities.
    Curtis JL
    Md Med J; 1997 Oct; 46(9):481-5. PubMed ID: 9327650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with the use of intrusive measures at a tertiary care facility for children and youth with mental health and developmental disabilities.
    Stewart SL; Baiden P; Theall-Honey L
    Int J Ment Health Nurs; 2013 Feb; 22(1):56-68. PubMed ID: 22738390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical assessment. Its role in comprehensive psychiatric evaluation.
    Madrid A; Marachi JP
    Child Adolesc Psychiatr Clin N Am; 1999 Apr; 8(2):257-70, vi. PubMed ID: 10202589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of psychotropic medication for children in foster care.
    Crismon ML; Argo T
    Child Welfare; 2009; 88(1):71-100. PubMed ID: 19653454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive-adaptive disabilities.
    Calles JL
    Pediatr Clin North Am; 2011 Feb; 58(1):189-203, xii. PubMed ID: 21281856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental pharmacology.
    van den Anker JN
    Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of psychotropic agents for children with psychosomatic problems and developmental disorders].
    Ishizaki Y
    Nihon Rinsho; 2012 Jan; 70(1):130-4. PubMed ID: 22413507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing more psychotropic medications for children: what does the increase mean?
    Conrad P
    Arch Pediatr Adolesc Med; 2004 Aug; 158(8):829-30. PubMed ID: 15289260
    [No Abstract]   [Full Text] [Related]  

  • 15. Executive function deficits in children with fetal alcohol spectrum disorders (FASD) measured using the Cambridge Neuropsychological Tests Automated Battery (CANTAB).
    Green CR; Mihic AM; Nikkel SM; Stade BC; Rasmussen C; Munoz DP; Reynolds JN
    J Child Psychol Psychiatry; 2009 Jun; 50(6):688-97. PubMed ID: 19175817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical clinical issues regarding child and adolescent psychopharmacology.
    Kutcher S
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):245-60. PubMed ID: 10674199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of psychotropic drugs in children, adolescents and subjects with intellectual disability: a review].
    Lazzeretti L; Pracucci C; Benni L; Godini L; Talamba GA; Faravelli C
    Riv Psichiatr; 2011; 46(1):1-17. PubMed ID: 21446107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revising a medication education program on an inpatient child and adolescent psychiatric unit.
    Eisenmann CM
    J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):42-7. PubMed ID: 22165839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing psychopathology in individuals with developmental disabilities.
    Rush KS; Bowman LG; Eidman SL; Toole LM; Mortenson BP
    Behav Modif; 2004 Sep; 28(5):621-37. PubMed ID: 15296521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.